<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nadzila Anindya Tejaputri</style></author><author><style face="normal" font="default" size="100%">Ade Arsianti</style></author><author><style face="normal" font="default" size="100%">Fona Qorina</style></author><author><style face="normal" font="default" size="100%">Qotrunnada Fithrotunnisa</style></author><author><style face="normal" font="default" size="100%">Norma Nur Azizah</style></author><author><style face="normal" font="default" size="100%">Rista Putrianingsih</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anticancer Activity of Ruellia britoniana Flower on Cervical HeLa Cancer Cells</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anticancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Cervical HeLa cells</style></keyword><keyword><style  face="normal" font="default" size="100%">Ruellia brittoniana</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February  2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">29-34</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Cervical cancer ranks 4&lt;sup&gt;th&lt;/sup&gt; in terms of the mortality rates and incidence of all cancers in women (GLOBOCAN 2018). In last decade, there is a significance progress in cancer therapy followed by an increase in the cost of cancer treatment. Therefore, it is necessary to have therapeutic innovations that are expected to reduce the cost of cervical cancer therapy. One therapeutic innovation that is currently being intensively carried out is herbal medicine. Some researchers have found that some plant extracts have anti-cancer properties that can be an alternative treatment for cancer, such as some plants with the genus &lt;em&gt;Ruellia&lt;/em&gt;, such as &lt;em&gt;Ruellia tuberosa &lt;/em&gt;and &lt;em&gt;Ruellia squarrosa&lt;/em&gt;. However, research on the anticancer activity of the species of &lt;em&gt;Ruellia brittoniana&lt;/em&gt;, especially the flowers, is still limited. &lt;strong&gt;Objective: &lt;/strong&gt;Aim of this study is to examine anti-cervical cancer activity of &lt;em&gt;R. brittoniana&lt;/em&gt; flower. &lt;strong&gt;Methods: &lt;/strong&gt;&lt;em&gt;R.brittoniana&lt;/em&gt; flowers were obtained from Depok, West Java, Indonesia. The flowers are extracted gradually with n-hexane, ethyl acetate, and ethanol solvents. The extracts were evaluated for anticancer activity by MTT method.&lt;strong&gt; Results: &lt;/strong&gt;IC&lt;sub&gt;50&lt;/sub&gt; values for ethanol extract, ethyl acetate extract and n-hexane extract of &lt;em&gt;R. brittoniana&lt;/em&gt; flowers are 116.55 ppm, 52.62 ppm, and 123.09 ppm, respectively, which indicating that ethanol extract has moderate anticancer activity, while ethyl acetate and n-hexane extract of &lt;em&gt;R. brittoniana&amp;nbsp;&lt;/em&gt;flowers have weak anticancer activity.&lt;strong&gt; Conclusion:&lt;/strong&gt; Ethanol, ethyl acetate, and n-hexane extract of &lt;em&gt;R.brittoniana&lt;/em&gt; flowers have a potential to become natural anti-cervical cancer.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">29</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Nadzila Anindya Tejaputri&lt;sup&gt;1&lt;/sup&gt;, Ade Arsianti&lt;sup&gt;2,3,&lt;/sup&gt;*, Fona Qorina&lt;sup&gt;1&lt;/sup&gt;, Qotrunnada Fithrotunnisa&lt;sup&gt;1&lt;/sup&gt;, Norma Nur Azizah&lt;sup&gt;3&lt;/sup&gt;, Rista Putrianingsih&lt;sup&gt;2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Medical Student, Faculty of Medicine University of Indonesia, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Medical Chemistry, Faculty of Medicine, University of Indonesia, Depok, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Drug Development Research Cluster, Drug Discovery Division, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, University of Indonesia, Jalan Salemba Raya 6 Jakarta 10430, INDONESIA&lt;/p&gt;
</style></auth-address></record></records></xml>